Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Non-Hodgkin lymphoma stories

Oct 30, 2026

Bayer wins Roundup cancer trial as jury rejects claims from three women

A St. Louis jury ruled in favor of Bayer in a trial over claims that its Roundup weedkiller caused cancer in three women, marking the company's first trial victory since a Supreme Court ruling on its broader settlement efforts.

Oct 30, 2026·4 sources
00
May 30, 2026

Incyte Blood Cancer Drug Combo Reduces Disease Progression Risk in Aggressive Lymphoma

Incyte's Monjuvi as part of a multi-drug regimen for an aggressive form of non-Hodgkin lymphoma reduced the risk of disease progression, relapse or death, though with a high side-effect rate.

May 30, 2026·1 source
00

Top claims

  • ▪Jefferies analysts noted that the October 29, 2026 St. Louis verdict provided a positive initial datapoint regarding plaintiffs' remaining legal arguments in the Roundup litigation
  • ▪Bayer continues to face approximately 65,000 pending Roundup lawsuits in U.S. state and federal courts
  • ▪The St. Louis jury rejected the plaintiffs' claims that Roundup weedkiller was defectively designed, unreasonably dangerous, and sold negligently by Monsanto

Topics

U.S. Supreme CourtJudiciaryProduct liability lawGlyphosateEnvironmental and Occupational HealthFederal preemptionSupreme Court decisionsEnvironmental Protection AgencyPesticide & herbicide exposureCancerDrug Approval and Clinical TrialsCancer treatment breakthroughsDrug Policy, Pricing & ApprovalCancer treatment

Related entities

United States Environmental Protection Agency